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Summary
To identify Chinese geneticists’ views of ethical issues in
genetic testing and screening, a national survey was con-
ducted. Of 402 Chinese geneticists asked to participate,
255 (63%) returned by mail anonymous questionnaires.
The majority of respondents thought that genetic testing
should be offered in the workplace for a-antitrypsin de-
ficiency (95%) and the predisposition of executives to
heart disease, cancer, and diabetes (94%); that genetic
testing should be included in preemployment physical
examinations (86%); that governments should require
premarital carrier tests (86%), newborn screening for
sickle cell (77%), and Duchenne muscular dystrophy
(71%); and that children should be tested for genes for
late-onset disorders such as Huntington disease (85%),
susceptibility to cancers (85%), familial hypercholester-
olemia (84%), alcoholism (69%), and Alzheimer disease
(61%). Most believed that partners should know each
other’s genetic status before marriage (92%), that car-
riers of the same defective gene should not mate with
each other (91%), and that women should have a pre-
natal diagnosis if medically indicated (91%). The ma-
jority said that in China decisions about family planning
were shared by the couple (82%). More than half had
views that, in China, there were no laws to prohibit
disability discrimination (64%), particularly to protect
people with adult polycystic kidney disease (57%), cystic
fibrosis (56%), or genetic predisposition to other dis-
eases (50%). To some extent, these results might provide
a basis for a discussion of eugenics in China, particularly
about China’s Maternal and Infant Health Care Law
(1994).
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Introduction
Genetic testing and screening are hot topics that stim-
ulate widespread discussion and debate, not only among
genetics professionals, but among clinicians and scien-
tists generally, and increasingly these topics involve the
wider public in developed countries. Views are expressed
in the scientific and general press, and through other
media, about the likely benefits and dangers that may
result from genetic testing and screening (Harper and
Clarke 1997).
However, there is much less debate about genetic test-
ing and screening in developing countries, where ∼95%
of the world’s future children will be born. To some
extent, this situation reflects the lack of genetics services
in these countries. A majority (3,330) of the estimated
5,000 specialists in medical genetics worldwide work in
developed countries, which have an overall geneticist/
population ratio of ∼1:222,000, compared with a ratio
of ∼1:700,000 for eastern European countries and ∼1:
3,700,000 for developing countries (Wertz et al. 1995).
Clinicians, scientists, and the public in developing coun-
tries are focused on the struggle to improve basic health
care. Given the problems of poverty, illiteracy, low con-
traceptive use, and high infant mortality (Galjaard
1997), they have relatively little interest in the devel-
opment of genetics research and services.
China, however, is an exception, having to some ex-
tent made genetics a priority. For example, in the 1960s
cytogenetics technology was introduced to China, and
in the 1970s chorionic villi sampling was performed in
some hospitals (Luo 1988). Since the 1980s, molecular-
genetic techniques have been used in genetic research
and counseling in several national genetic laboratories
(Luo 1988; Fu et al. 1995). In 1988, in vitro fertilization,
embryo transfer, and gamete intrafallopian transfer were
available in several teaching hospitals (Zhang et al.
1988). In 1992, the techniques of enrichment of fetal
cells from maternal blood, for prenatal diagnosis and
sex determination during the first trimester, were intro-
duced to China. In 1994, China launched its Human
Genome Project (Li 1994). Gene therapy for patients
with hemophilia B has also been used in clinical trials
(Fu et al. 1995).
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On the other hand, according to international stan-
dards, genetics services in China are underdeveloped be-
cause of a lack of funding and expertise, as well as the
large number of people with genetic conditions (Harper
and Harris 1986; Luo 1988). Chinese geneticists have
expressed their views about ethical, legal, and social is-
sues in genetics research and practice in China. Their
concerns are, however, quite different from those of
other countries, particularly developed nations (Mao
1996, 1997; Mao and Wertz 1997).
The term “eugenics” has many meanings. Eugenics
can be voluntary or coerced, government sponsored or
individual, a “science” or a social policy, based on the
welfare of individuals or on the welfare of society or a
nation (Paul 1992; Garver and Garver 1994; Larson
1995; “Brave New Now” 1997). Most people in de-
veloped countries today think of eugenics as a coercive
social program enforced by the state for the good of
society. Since China announced the Maternal and Infant
Health Care Law (1994), it has provoked widespread
concern in the international scientific community, be-
cause of some of its eugenic content (“China’s Miscon-
ception of Eugenics” 1994; “Western Eyes on China’s
Eugenic Law” 1995; O’Brien 1996; “Brave New Now”
1997; Harper and Clarke 1997; Morton 1998). There
has, however, been very little international discussion on
what eugenics means for Chinese geneticists and why it
is alive and well in China. In this article, I will present
Chinese geneticists’ views of ethical issues in genetic test-
ing and screening and will discuss the likely basis of
eugenics in China, particularly China’s Maternal and
Infant Health Care Law (1994).
Subject and Methods
An anonymous international questionnaire including
50 questions on ethical issues, which was used in an
international study comparing attitudes of geneticists in
37 nations (Wertz and Fletcher 1993), was distributed
to 402 geneticists in 30 provinces and autonomous
regions in mainland China. These geneticists were reg-
istered members of the Chinese Association of Medical
Genetics, the Human and Medical Genetics Branch of
the Chinese Society of Genetics, or the Chinese Society
of Family Planning, all of which are headed by the Chi-
nese Association for Science and Technology but are af-
filiated with different departments of state (the Ministry
of Public Health, the Chinese Academy of Science, and
the National Committee of Family Planning, respec-
tively). In all, 255 geneticists (63%) responded. All of
the respondents’ comments were translated into English.
The completed questionnaires were mailed to the Di-
vision of Social Science, Ethics and Law, at the Shriver
Center for Mental Retardation, in the United States, for
statistical analysis. Coded data were entered into the
SPSSX program (from Statistical Package for the Social
Sciences) on an IBM 3090 computer (Mao and Wertz
1997).
Results
The questionnaire asked whether genetic testing
should be offered for job application–related situations;
the majority of respondents thought that genetic testing
should be offered to workers for a-antitrypsin deficiency
in a very dirty workplace (95%) and for executives’ pre-
disposition to heart disease, cancer, and diabetes (94%).
The questionnaire listed several ethical issues designed
to survey respondents’ opinions. The majority of re-
spondents agreed that partners should know each other’s
genetic status before marriage (92%), that carriers of the
same defective gene should not mate with each other
(91%), that women should have prenatal diagnosis if it
is medically indicated (91%), that genetic testing should
be included in preemployment physical examinations
(86%), and that governments should require premarital
carrier tests (86%) and newborn screening for sickle cell
anemia (77%) and for Duchenne muscular dystrophy
(DMD) (71%) (table 1). Sixty-five percent agreed with
the statement that “an important goal of newborn
screening is to identify and counsel parental carriers be-
fore next pregnancy.”
When Chinese geneticists were asked whether parents
should be able to have their children tested for late-onset
disorders or predisposition to such diseases, the majority
said that, if parents request it, children should be tested
for Huntington disease (85%), susceptibility to cancers
(85%), familial hypercholesterolemia (FH) (84%), and
predisposition to alcoholism (69%) or to Alzheimer dis-
ease (AD) (61%) (table 2).
When asked whether there was a prevailing pattern
for decisions about family planning, most (82%) said
that decisions about family planning were shared by the
couple. The minority believed it to be determined by the
husband’s (10%), doctor’s (3%), wife’s (2%), husband’s
parents’ (2%), or wife’s parents’ (1%) views (table 3).
When asked whether there were any laws prohibiting
disability discrimination, more than half of Chinese re-
spondents said that there were no such laws in China
(64%), particularly to protect people with adult poly-
cystic kidney disease (57%), cystic fibrosis carriers
(56%), and persons with genetic predisposition to other
diseases (50%) (table 4). Ninety-four percent agreed
with the statement that “it is not fair for a child to be
brought into the world with a serious genetic disorder
if the birth could have been prevented;” 79% thought
that some disabilities will never be overcome even with
maximum social support, and the majority would not
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Table 1
Views on Various Ethical Issues
Ethical Issue
Agree
(%)
Neither Agree nor
Disagree
(%)
Disagree
(%)
Partners should know their genetic status before marriage 92 7 1
Carriers should not mate with each other 91 5 4
Woman should have prenatal diagnosis if medically indicated 91 8 1
Genetic testing should be included in preemployment physical examinations 86 12 2
Governments should require premarital carrier tests 86 10 4
Governments should require newborn screening for sickle cell 77 21 2
Governments should require newborn screening for DMD 71 22 7
Woman’s abortion decision should be her own 40 19 41
Patients should have right not to know test results 29 28 43
Useless to test if the only treatment is abortion 27 10 63
Prenatal diagnosis should be provided regardless of intended use 13 10 77
Table 2
Views on the Testing of Children for Late-Onset
Disorders
DISORDER
CHILDREN SHOULD
BE TESTEDa
Yes
(%)
No
(%)
Huntington disease 85 15
Susceptibility to cancer 85 15
FH 84 16
Alcoholism 69 31
AD 61 39
a For gene for either adult onset or predisposition.
support disabled parents’ decisions to have disabled chil-
dren. Ninety percent thought that an ethical code or
guidelines for genetics services are needed in China, and
50% said that public education in genetics should be
the top priority of the government health budget.
Discussion
Genetic testing, which is offered to individuals and
families who are at high risk, is either the analysis of a
specific gene—and/or its product or function—or other
DNA and chromosome analysis, to detect or exclude an
alteration likely to be associated with a genetic disorder.
Genetic screening is applied to large population groups
with unknown excess risk to individuals. Screening is
frequently part of government-sponsored public-health
programs and may be a preliminary procedure that iden-
tifies people at elevated risk of genetic disease, but it
does not provide a definitive diagnosis (Wertz et al.
1995; Harper and Clarke 1997).
In this survey, questions about newborn genetic
screening were asked. This is because newborn screening
for phenylketonuria (PKU) and hypothyroidism has
saved many thousands of infants worldwide from these
two severe disorders and therefore has created a large
store of goodwill and ethical credit in favor of genetic
screening programs (Harper and Clarke 1997). This sur-
vey shows that 77% of Chinese respondents thought
that the government should require newborn screening
for sickle cell disease (table 1). The figure is higher than
those for the United Kingdom (13%) and the United
States (11%) (Wertz 1995). One explanation for this
difference might be that Chinese geneticists believe that
identification of parents and newborns who are hetero-
zygous carriers is important, since sickle cell disease is
very common in China. Although newborn screening for
DMD fails to meet the established World Health Or-
ganization guidelines for the adoption of a screening
program (Wilson and Jungner 1968), it might be helpful
to avoid diagnostic delays and to permit families to seek
genetic counseling before they embark on another preg-
nancy. The mothers of infants in the United Kingdom
appeared to have more enthusiasm for newborn screen-
ing for DMD, since 94% of them would accept such
screening (Smith et al. 1990). When geneticists around
the world were asked whether the government should
require newborn screening for DMD, 71% of Chinese
respondents, 64% of respondents in the United States,
and 49% of respondents in the United Kingdom thought
that the governments should do so (table 1) (Wertz
1995). On this issue, the difference between geneticists
in China and the United Kingdom may be that Chinese
geneticists believe that newborn screening for DMD is
a public-health issue, and that, because it is very expen-
sive in China, it must be government sponsored. Ge-
neticists in the United Kingdom are concerned about the
state directing genetic decisions, rather than individuals
making the choices (Harper and Clarke 1997). In ad-
dition, the majority of European, North American, and
Chinese geneticists would recommend newborn screen-
ing for cystic fibrosis, FH, fragile X, and thalassemia if
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Table 3
Views on Family Decision Making
Agree
(%)
Couple should make decision 82
Husband should make decision 10
Doctor should make decision 3
Wife should make decision 2
Husband’s parents should make decision 2
Wife’s parents should make decision 1
Table 4
Views on Laws Prohibiting Disability Discrimination
INTENT
COUNTRY SHOULD HAVE
LAW
Yes
(%)
No
(%)
To prohibit disability discrimination 36 64
To protect people with adult poly-
cystic kidney disease
43 57
To protect cystic fibrosis carriers 44 56
To protect people with genetic pre-
disposition to other diseases
50 50
automated DNA diagnostic techniques were available
on newborn blood spots, even though there is no proof
that the newborn benefit from such screening (Wertz
1995). It may still be reasonable to offer such screening
if the disease has its onset in childhood and if the child’s
family finds it helpful to have an early diagnosis (Harper
and Clarke 1997).
The advent of DNA-based testing across a wide and
increasing range of late-onset genetic disorders is a chal-
lenge to conventional thinking about medical tests. This
is because those individuals receiving an abnormal result
are sometimes considered, by themselves and others, to
“have the disease,” even though they are still presymp-
tomatic. Testing children for late-onset genetic disorders
may have serious ethical and social implications. This
survey shows that most Chinese geneticists thought that
children should be tested for susceptibility to cancers
and FH (table 2). Most geneticists in Europe and North
America expressed the same view, since they saw early
diagnosis and early treatment of these disorders as being
a potential benefit to the child (Wertz 1995). However,
most of them thought that testing for Huntington dis-
ease, alcoholism, and AD provided no medical benefit
to the child (Wertz 1995). They opposed the testing of
children, on the grounds that testing was an affront to
the autonomy of the child, who, on reaching adulthood,
should be allowed to make his or her own decisions on
whether to be tested. Most Chinese geneticists favored
such testing (table 2), on the grounds that parents should
be able to decide for their children and should have the
power to direct their children’s lives. This cultural di-
vision reflects the extension of individual autonomy in
developed countries, to include preservation of the au-
tonomy of minors. In China, the child is often seen as
part of a collectivity (the family), rather than as a po-
tentially autonomous individual.
Although, thus far, employers’ requests for employ-
ment-related genetic testing have been few (Harper and
Clarke 1997), questions on whether such testing should
be offered were included in this survey because there is
an ethical conflict between the individual’s rights and
the employer’s interest. More and more Western genet-
icists have expressed their concerns on the likelihood of
misuse of such testing, which would cause harm to those
employees with genetic conditions (i.e., genetic discrim-
ination; Harper and Clarke 1997). This survey shows,
however, that most Chinese geneticists agreed that such
testing should be offered as a part of a routine physical
examination. This result may demonstrate that Chinese
geneticists hold strong social views on genetics services
(Mao and Wertz 1997).
One purpose of genetics services is to provide accu-
rate, full, and unbiased information that individuals and
families may use in making decisions. Traditionally,
China has been a paternalistic society and parents have
had absolute power to make family decisions. To explore
the current situation of family planning in China, ques-
tions on this issue were asked. This survey shows that,
of 255 respondents, 51% were female (Mao and Wertz
1997). Most of them thought that family planning was
currently shared by the couple. This figure is quite sim-
ilar to that in developed countries (Wertz 1995) and, in
part, may reflect socioeconomic changes that have oc-
curred in China during the past 4 decades.
In 1994, China’s population reached 1.2 billion. Now
China is pushing on with its goal of ensuring that the
country’s population is X1.3 billion by the end of the
century and !1.4 billion by 2010. The basic means of
reaching the goal are birth control and the “one couple,
one child” policy, which stipulates that each Chinese
couple is legally allowed to have only one child (Wu
1994). Ironically, China has paid a huge socioeconomic
price for ridiculing the theory and practice of birth con-
trol and family planning during the 1950s and 1960s.
On the other hand, according to a national sampling
survey in 1987, there were 51.64 million disabled people
(4.9% of the total population) in China. Of these, 54.3%
(i.e., 2.66% of the total population) were children. The
majority of these disabilities (64.91%) are due to post-
natal diseases and injuries, whereas 35.09% are due to
birth defects and genetic diseases (Chen and Simeonsson
1993; Ming and Jixiang 1993). One aim of this survey
is to investigate geneticists’ attitudes toward the social
and legal aspects of genetics. It would be necessary to
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ask whether there are laws or regulations in China that
prohibit discrimination against people with disabilities.
This survey shows that more than half of Chinese re-
spondents thought that there were no such laws or reg-
ulations in China, particularly to protect people with
genetic conditions. This may be because, although the
rights of people with disabilities have been protected
constitutionally in China, there are no Chinese laws
specifying whether people with genetic conditions
should be protected as disabled people. This survey also
suggests that most Chinese still regard disabilities as a
severe burden for both family and society. Population
and disability issues are universal. As the history of the
Western eugenics movement has shown, these issues are
to some extent likely to produce a social “medium” or
environment for the “birth and growth” of eugenics
(Paul 1995).
Historically, cost effectiveness appears to be one of
the major issues concerning Western eugenicists. A typ-
ical example of this was seen in 1923, when the Amer-
ican Eugenics Society tried to justify the expense of
building enough institutions to house and separate all
the mentally retarded people by calculating that the
$25,000(U.S.) spent on segregating the original mentally
retarded persons for life would have saved the state
1$2,000,000 in later costs. It also added that sterilizing
the original mentally retarded people would have cost
!$150 (Larson 1995). Although it is questionable
whether economic calculations would really work in ge-
netics, some Western geneticists still regard cost effect-
iveness as an important factor in genetics services. This
is because the clinical genetics services already available
have been shown to be highly cost effective, mainly be-
cause of the high costs of medical and psychosocial care
for the chronically handicapped in Western countries.
For example, in the Netherlands seven regional clinical
genetics centers involved in pre- and postnatal chro-
mosome analysis, biochemical and DNA diagnosis, and
genetic counseling supported by the national health in-
surers cost ∼$50 million/year. As a result of their com-
bined activities, the birth of 800–1600 severely handi-
capped children is avoided every year. The costs of their
medical and psychosocial care would have been $500
million–$1 billion during an average life span of 10 years
(Galjaard 1997). Moreover, it even has been predicted
that the most enforced codes of medical practice, par-
ticularly in genetics services, may be based on cost-ef-
fectiveness analysis rather than on ethical considerations
for the future (Wertz 1997).
The concept of cost effectiveness may have different
meanings for Chinese geneticists. This is because, unlike
Cuba, where a free health care system including genetic
testing and screening covers the entire population (Her-
edero 1992), genetics services in China are not free and
are expensive for most Chinese people. For instance, in
1987 the average income of a Chinese worker in a fac-
tory or university was ∼$30/mo, whereas the cost of
cytogenetic testing was $6–$20. On the basis of the pop-
ulation prevalence of chromosomal diseases in Sichuan
province (31.5/100,000) (Zhang et al. 1991), it is esti-
mated that there would be 346,500 persons with chro-
mosomal disorders in China at that time (in an overall
population 1.1 billion). If all of these cases were diag-
nosed cytogenetically, it would cost $2,000,000–
$7,000,000, which is equivalent to 69,300–231,000
workers’ monthly incomes. The costs of genetics services
have increased very rapidly in recent years because of
inflation and health-care reform, although such services
in China are still underdeveloped and fall far short of
the needs of people with genetic disorders.
The prevalence of PKU in the Chinese population is
∼6/100,000 people (Liu and Zuo 1986). Thus, there
would have been ∼72,000 people with PKU in 1994,
when the population was 1.2 billion. A Chinese study
analyzed the cost benefit of newborn screening for PKU
and estimated that the 10-year cost of screening, diag-
nosis, medical care, and dietary therapy for each PKU
case identified would be $4,000. If PKU infants were
not diagnosed and treated, the estimated cost of living
for one untreated, mentally retarded individual with a
mean life span of 40 years also would be $4,000. Income
loss, special education costs, and inability to contribute
to society would cause a total loss of x$20,000. The
long-term estimated benefits due to early screening, di-
agnosis, and treatment, minus the cost of screening and
treatment, therefore is ∼$20,000. Thus, the ratio of ben-
efit:cost ratio would be ∼5:1 (Zhou 1995). It is a pity,
however, that China is still unable to produce a low-
phenylalanine diet in quantities large enough to provide
adequate therapy for most affected babies (Luo 1988),
even though the PKU test is cheap and newborn screen-
ing for PKU seems to be cost effective in China. All of
these actual situations most likely will lead Chinese
thinking to consider the use of other radical means, such
as abortion and sterilization, to reduce the incidence of
PKU (Mao and Wertz 1997).
The word “eugenics,” which currently is used more
widely in China than in the West, when directly trans-
lated into Chinese, is “yousheng” and “youyu,” which
mean “well bear” and “well rear.” The viewmost widely
held by Chinese geneticists is that eugenics implies pro-
cesses designed to ensure that children who are born are,
as far as possible, “normal.” How to achieve this, in the
context of strict family limitation, has emerged as the
most significant difference, in the approach to medical
genetics, between China and the West (Harper and Har-
ris 1986). This survey was conducted in 1993, 1 year
before China promulgated the Maternal and Infant
Health Care Law (1994). In their comments, almost all
respondents said that the goal of human genetics was
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“improvement of the population quality, decrease of the
population quantity, and furtherance of eugenic prin-
ciples” and agreed that “an important goal of genetic
counseling is to reduce the number of deleterious genes
in the population” (Mao 1997, p. 20). Chinese geneti-
cists also were extremely pessimistic about directive
counseling after prenatal diagnosis for almost all genetic
disorders (Mao and Wertz 1997). The majority of them
would advise voluntary surgical sterilization for a single
blind woman on welfare who had a 50% risk of blind-
ness in children (88%), for a woman with fragile X who
was living in an institutional setting (73%), and for a
cystic fibrosis carrier-carrier couple (52%) (Mao and
Wertz 1997). This survey reveals that most Chinese ge-
neticists thought that partners should know their genetic
status before marriage, that carriers of the same defective
gene should not marry each other, and that women
should have prenatal diagnosis if medically indicated.
These views were expressed, to some extent, in the Chi-
nese Maternal and Infant Health Care Law (1994).
The contentious articles of the law are cited as follows
(Maternal and Infant Health Care Law 1994):
Article 8.—The premarital physical checkup shall in-
clude the examination of the following diseases:
1. Genetic diseases of a serious nature;
2. Target infectious diseases;
3. Relevant mental disease.
Article 10.—Physicians shall, after performing the pre-
marital physical checkup, explain and give medical ad-
vice to both the male and the female who have been
diagnosed with a certain genetic disease of a serious
nature that is considered to be inappropriate for child-
bearing from a medical point of view; the two may be
married only if both sides agree to take long-term con-
traceptive measures or to get the ligation operation for
sterility. However, a marriage that is forbidden as stip-
ulated by provisions of the Marriage Law of the People’s
Republic of China is not included herein.
Article 16.—If a physician detects or suspects that a
married couple in their childbearing age suffers from
genetic disease of a serious nature, the physician shall
give medical advice to the couple, and the couple in their
childbearing age shall take measures in accordance with
physician’s medical advice.
Article 18.—The physician shall explain to the mar-
ried couple and give them medical advice about termi-
nation of pregnancy if one of the following cases is de-
tected in the prenatal diagnosis:
1. The fetus is suffering from genetic disease of a se-
rious nature;
2. The fetus has a defect of a serious nature;
3. Continued pregnancy may threaten the life and
safety of the pregnant woman or seriously impair her
health because of the serious disease she suffers from.
In these articles, “genetic diseases of a serious nature”
refers to diseases that are caused congenitally by genetic
factors, that may totally or partially deprive the victim
of the ability to live independently, that are highly pos-
sible to recur in generations to come, and that are con-
sidered medically inappropriate for reproduction; “rel-
evant mental diseases” refers to schizophrenia, manic-
depressive psychosis, and other mental diseases of a
serious nature.
The international opinions on the Chinese law vary.
Some Western geneticists have fiercely criticized the law
as an “abuse of genetics” and a “violation of human
rights” (Morton 1998). Others have said that “in a coun-
try where millions of female children vanish, and many
children with developmental abnormalities are left to
die, the lawmight represent an improvement” (Beardsley
1997, pp. 33–34). Frankly speaking, in China too there
is opposition to the law, from some geneticists who did
their training in Western countries. For example, they
oppose some radical measures such as “sterilization of
people with IQ less than 60” and the use of term “eu-
genics” in the early draft of the law. Interestingly, voices
of Chinese geneticists are heard defending the law. Some
examples are “China now has a population of 50million
handicapped. Without effective action, China will have
an even larger population with serious hereditary dis-
eases and it will naturally impose a grave social problem
as regards their livelihood, social and cultural devel-
opment as a whole and even the quality of the whole
population” (“Opportunity for Depth in Chinese Eu-
genics Debate” 1998, p. 109); “the law was terribly
misinterpreted”; “the law was needed to supplement the
one-child policy and had no intention of enforcing eu-
genic aspects” (Takebe 1997, p. 89); “the law only fa-
cilitates practices common for decades in Western coun-
tries, and there is no similarity between what is practiced
in China and Hitler’s concept of eugenics” (Maddox and
Swinbanks 1995, p. 549). The survey results do, how-
ever, suggest that social, economic, and cultural differ-
ences most likely will give rise to a disagreement between
China and the West, on the issue of eugenics.
Public education in genetics is thought to be an ef-
fective approach to reduce the incidence of genetic dis-
eases, although it needs a huge and long-term investment
from the government (Harper and Clarke 1997). This
survey suggests that at least half of Chinese geneticists
appear to realize the importance of the issue. On the
other hand, genetics education in China has not covered
any ethical issues yet (McCaffrey 1989). One ethicist
who advised the drafting of the Chinese law admitted
that bioethics has just started to be discussed and was
not considered seriously when the law was drafted (Tak-
ebe 1997). This survey, however, reveals that most Chi-
nese geneticists think that ethical guidelines are necessary
for the improvement of genetics services in China. Al-
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though theMinistry of Public Health of China published
a brief ethical code for medical professionals in 1988
(Qiu 1993), at the moment there are not any ethical
guidelines for genetics services in China. A group of
experts from both developed and developing countries,
including China, sponsored by the World Health Or-
ganization, has drafted international guidelines on eth-
ical issues in medical genetics and on the provision of
genetics services. The guidelines not only provide ethical
principles for genetics services and research but also em-
phasize respect for cultural, social, and religious diversity
(World Health Organization 1998). It therefore is ex-
pected that the guidelines will be introduced into China
and will serve as a framework for Chinese geneticists in
their practice and research. Perhaps in this practical way,
such guidelines could bridge the social and cultural gap
between Chinese geneticists and their Western counter-
parts, could help to clarify the nature of eugenics, and
could allow a consensus on the ethical, legal, and social
issues of genetics in the future.
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